Auto1 Group SE

  • WKN: A2LQ88
  • ISIN: DE000A2LQ884
  • Land: Deutschland


Notiert in Frankfurter Wertpapierbörse 
ISIN DE000A2LQ884 
Index MDAX, Regulierter Markt (Prime Standard) 
Letzte Dividende  

Aktuelle Aktionärsstruktur

Gründer 25,3%
Softbank 18,2%
OUR993 S.à r.l. 6,6%
Morgan Stanley 5,8%
Target Global 5,0%
Sonstige Aktionäre / Free Float 39,0%

Aktionärsstruktur zum Notierungsbeginn

Fidelity Mgmt 5,48%*
Piton Capital 3,4%*
Baillie Gifford 3,2%*
Lone Pine Capital 3,0%*
*in % der ausstehenden Aktien

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021